Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015301814> ?p ?o ?g. }
- W3015301814 endingPage "1490" @default.
- W3015301814 startingPage "1479" @default.
- W3015301814 abstract "Objective: Enhanced expression of PAI-1 (plasminogen activator inhibitor-1) has been implicated in atherosclerosis formation in humans with obesity and metabolic syndrome. However, little is known about the effects of pharmacological targeting of PAI-1 on atherogenesis. This study examined the effects of pharmacological PAI-1 inhibition on atherosclerosis formation in a murine model of obesity and metabolic syndrome. Approach and Results: LDL receptor-deficient ( ldlr −/− ) mice were fed a Western diet high in cholesterol, fat, and sucrose to induce obesity, metabolic dysfunction, and atherosclerosis. Western diet triggered significant upregulation of PAI-1 expression compared with normal diet controls. Addition of a pharmacological PAI-1 inhibitor (either PAI-039 or MDI-2268) to Western diet significantly inhibited obesity and atherosclerosis formation for up to 24 weeks without attenuating food consumption. Pharmacological PAI-1 inhibition significantly decreased macrophage accumulation and cell senescence in atherosclerotic plaques. Recombinant PAI-1 stimulated smooth muscle cell senescence, whereas a PAI-1 mutant defective in LRP1 (LDL receptor-related protein 1) binding did not. The prosenescent effect of PAI-1 was blocked by PAI-039 and R2629, a specific anti-LRP1 antibody. PAI-039 significantly decreased visceral adipose tissue inflammation, hyperglycemia, and hepatic triglyceride content without altering plasma lipid profiles. Conclusions: Pharmacological targeting of PAI-1 inhibits atherosclerosis in mice with obesity and metabolic syndrome, while inhibiting macrophage accumulation and cell senescence in atherosclerotic plaques, as well as obesity-associated metabolic dysfunction. PAI-1 induces senescence of smooth muscle cells in an LRP1-dependent manner. These results help to define the role of PAI-1 in atherosclerosis formation and suggest a new plasma-lipid-independent strategy for inhibiting atherogenesis." @default.
- W3015301814 created "2020-04-17" @default.
- W3015301814 creator A5008077310 @default.
- W3015301814 creator A5020583341 @default.
- W3015301814 creator A5043595868 @default.
- W3015301814 creator A5044165171 @default.
- W3015301814 creator A5050622790 @default.
- W3015301814 creator A5060280816 @default.
- W3015301814 creator A5063870060 @default.
- W3015301814 creator A5070266119 @default.
- W3015301814 date "2020-06-01" @default.
- W3015301814 modified "2023-10-13" @default.
- W3015301814 title "Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome" @default.
- W3015301814 cites W151540657 @default.
- W3015301814 cites W1579491283 @default.
- W3015301814 cites W1965865800 @default.
- W3015301814 cites W1965876706 @default.
- W3015301814 cites W1970314658 @default.
- W3015301814 cites W1971011047 @default.
- W3015301814 cites W1972325849 @default.
- W3015301814 cites W1978888457 @default.
- W3015301814 cites W1981208326 @default.
- W3015301814 cites W1982283178 @default.
- W3015301814 cites W1982519018 @default.
- W3015301814 cites W1988193334 @default.
- W3015301814 cites W1988694095 @default.
- W3015301814 cites W1989565327 @default.
- W3015301814 cites W2005248738 @default.
- W3015301814 cites W2016259832 @default.
- W3015301814 cites W2020245957 @default.
- W3015301814 cites W2038411073 @default.
- W3015301814 cites W2039451444 @default.
- W3015301814 cites W2041788615 @default.
- W3015301814 cites W2050527278 @default.
- W3015301814 cites W2050915090 @default.
- W3015301814 cites W2057083662 @default.
- W3015301814 cites W2061379276 @default.
- W3015301814 cites W2071770551 @default.
- W3015301814 cites W2074103997 @default.
- W3015301814 cites W2075420392 @default.
- W3015301814 cites W2085742383 @default.
- W3015301814 cites W2092292921 @default.
- W3015301814 cites W2103403127 @default.
- W3015301814 cites W2106988701 @default.
- W3015301814 cites W2107313543 @default.
- W3015301814 cites W2107969192 @default.
- W3015301814 cites W2112455934 @default.
- W3015301814 cites W2113506865 @default.
- W3015301814 cites W2120559894 @default.
- W3015301814 cites W2123105612 @default.
- W3015301814 cites W2131098631 @default.
- W3015301814 cites W2133854883 @default.
- W3015301814 cites W2136043856 @default.
- W3015301814 cites W2144590229 @default.
- W3015301814 cites W2148142715 @default.
- W3015301814 cites W2153245546 @default.
- W3015301814 cites W2153729560 @default.
- W3015301814 cites W2156104118 @default.
- W3015301814 cites W2156573227 @default.
- W3015301814 cites W2164224741 @default.
- W3015301814 cites W2167408582 @default.
- W3015301814 cites W2170874869 @default.
- W3015301814 cites W2172797119 @default.
- W3015301814 cites W2178875476 @default.
- W3015301814 cites W2184660913 @default.
- W3015301814 cites W2336672206 @default.
- W3015301814 cites W2410449798 @default.
- W3015301814 cites W2422782475 @default.
- W3015301814 cites W2465934854 @default.
- W3015301814 cites W2528215691 @default.
- W3015301814 cites W2529588494 @default.
- W3015301814 cites W2544670169 @default.
- W3015301814 cites W2610427402 @default.
- W3015301814 cites W2613753174 @default.
- W3015301814 cites W2621285299 @default.
- W3015301814 cites W2737249697 @default.
- W3015301814 cites W2739353751 @default.
- W3015301814 cites W2747556535 @default.
- W3015301814 cites W2768485358 @default.
- W3015301814 cites W2893769734 @default.
- W3015301814 cites W2903196728 @default.
- W3015301814 cites W2920564958 @default.
- W3015301814 cites W2993150161 @default.
- W3015301814 doi "https://doi.org/10.1161/atvbaha.119.313775" @default.
- W3015301814 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7255962" @default.
- W3015301814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32268785" @default.
- W3015301814 hasPublicationYear "2020" @default.
- W3015301814 type Work @default.
- W3015301814 sameAs 3015301814 @default.
- W3015301814 citedByCount "28" @default.
- W3015301814 countsByYear W30153018142020 @default.
- W3015301814 countsByYear W30153018142021 @default.
- W3015301814 countsByYear W30153018142022 @default.
- W3015301814 countsByYear W30153018142023 @default.
- W3015301814 crossrefType "journal-article" @default.
- W3015301814 hasAuthorship W3015301814A5008077310 @default.
- W3015301814 hasAuthorship W3015301814A5020583341 @default.
- W3015301814 hasAuthorship W3015301814A5043595868 @default.